 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Ken-Jec 40.
No reviews have yet been submitted. Be the first to review this drug.
Pregnancy Category Risk cannot be ruled out
Heart failure is linked to thinning of the bones and an increased risk of fractures, a new study indicates. The findings suggest that aggressive screening for...
DETROIT, Feb. 6, 2012 – A Henry Ford Hospital study has found that using two types of common asthma medications in combination reduces severe asthma...
A major head-to-head trial finds that aspirin is equally as good as warfarin in preventing stroke and death in heart failure patients. The researchers said...
Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new...
Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. The...
Looking for answers? Ask a question or go join the Ken-Jec 40 support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
